title: "End-stage" neurofibrillary tangle pathology in preclinical Alzheimer's disease: fact or fiction?
abstract: Among individuals who were cognitively intact before death, autopsies may reveal some Alzheimer's disease-type pathology. The presence of end-stage pathology in cognitively intact persons would support the hypothesis that pathological markers are epiphenomena. We assessed advanced neurofibrillary (Braak stages V and VI) pathology focusing on nondemented individuals. Data from the National Alzheimer's Coordinating Center database (n = 4,690 included initially) and from the Nun Study (n = 526 included initially) were analyzed, with antemortem information about global cognition and careful postmortem studies available from each case. Global cognition (final Mini-Mental State Examination scores (MMSE) and clinical 'dementia' status) was correlated with neuropathology, including the severity of neurofibrillary pathology (Braak stages and neurofibrillary tangle counts in cerebral neocortex). Analyses support three major findings: 1. Braak stage V cases and Braak VI cases are significantly different from each other in terms of associated antemortem cognition; 2. There is an appreciable range of pathology within the category of Braak stage VI based on tangle counts such that brains with the most neurofibrillary tangles in neocortex always had profound antemortem cognitive impairment; and 3. There was no nondemented case with final MMSE score of 30 within a year of life and Braak stage VI pathology. It may be inappropriate to combine Braak stages V and VI cases, particularly in patients with early cognitive dysfunction, since the two pathological stages appear to differ dramatically in terms of both pathological severity and antemortem cognitive status. There is no documented example of truly end-stage neurofibrillary pathology coexisting with intact cognition.
authors.affiliation: Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40536-0230, USA.
authors.forename: Erin L
authors.initials: EL
authors.lastname: Abner
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Kryscio
authors.forename: Frederick A
authors.initials: FA
authors.lastname: Schmitt
authors.forename: Karen S
authors.initials: KS
authors.lastname: Santacruz
authors.forename: Gregory A
authors.initials: GA
authors.lastname: Jicha
authors.forename: Yushun
authors.initials: Y
authors.lastname: Lin
authors.forename: Janna M
authors.initials: JM
authors.lastname: Neltner
authors.forename: Charles D
authors.initials: CD
authors.lastname: Smith
authors.forename: Linda J
authors.initials: LJ
authors.lastname: Van Eldik
authors.forename: Peter T
authors.initials: PT
authors.lastname: Nelson
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000473:pathology*; D000544:Alzheimer Disease / Q000473:pathology*; D001344:Autopsy / Q000379:methods; D001921:Brain / Q000473:pathology*; D003072:Cognition Disorders / Q000473:pathology; D018450:Disease Progression; D005260:Female; D006801:Humans; D008297:Male; D008609:Mental Status Schedule; D016874:Neurofibrillary Tangles / Q000473:pathology*; D009483:Neuropsychological Tests; D012720:Severity of Illness Index